Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies
Go back to Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies| AGENUS (NASDAQ: AGEN) | Delayed: 7.67 -0.42 (5.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.09 | 52 Week High | $7.49 | |||
| Open | $8.07 | 52 Week Low | $2.61 | |||
| Day High | $8.07 | P/E | N/A | |||
| Day Low | $7.60 | EPS | $-1.10 | |||
| Volume | 775,159 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 146.74 +0.62 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.12 | 52 Week High | $108.63 | |||
| Open | $145.93 | 52 Week Low | $71.39 | |||
| Day High | $146.84 | P/E | 81.07 | |||
| Day Low | $144.59 | EPS | $1.81 | |||
| Volume | 6,183,184 | |||||
